BioSpace News Archive

Business

WuXi Biologics to Install Industry’s Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

Wuxi Biologics announced that it has selected 4,000 liter (L) Custom Single Run (CSR®) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China.

March 20, 2018
·
1 min read
BioCapital

BioPharmX Cancels Presentation at Oppenheimer’s 28th Annual Healthcare Conference Due to Severe Weather

BioPharmX Corporation announces that it has cancelled its presentation at Oppenheimer’s 28th Annual Healthcare Conference in New York tomorrow, due to the winter storm warnings forecasted for the region.

March 20, 2018
·
1 min read
BioCapital

GlycoMimetics Announces Pricing of Public Offering of Common Stock At $17 Per Share

GlycoMimetics, Inc. announced the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $17.00 per share.

March 20, 2018
·
2 min read
Drug Development

Genentech’s Tecentriq Shows Promise for First-line Lung Cancer Treatment

Tecentriq’s Phase III results gives Genentech a lead for potentially becoming the first-line treatment for squamous non-small cell lung cancer.

March 20, 2018
·
3 min read
·
Mark Terry
FDA

FDA Grants Priority Review for Prostate Cancer Treatment

The FDA granted a Priority Review designation to Pfizer and partner Astellas Pharma for expanded use of Xtandi in prostate cancer treatment.

March 20, 2018
·
2 min read
·
Alex Keown
Drug Development

Ocugen’s Dry Eye Treatment Hit Its Primary Endpoint

Ocugen announced this morning that its mid-stage combination treatment hit its primary endpoint of tolerability in a proof-of-concept trial.

March 20, 2018
·
2 min read
·
Alex Keown
Drug Development

AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease

AstraZeneca’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released today.

March 20, 2018
·
2 min read
·
Alex Keown
Drug Development

Can Gilead Develop a Cure for HIV?

Gilead Sciences essentially created a cure for hepatitis C and may be well on its way to developing a cure for HIV-AIDS.

March 20, 2018
·
3 min read
·
Mark Terry
Drug Development

Arena Pharmaceuticals Shares Explode on Positive Ulcerative Colitis Trial Data

Arena Pharmaceuticals released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis.

March 20, 2018
·
3 min read
·
Mark Terry
Career Advice

5 Ways to Position Yourself for a Promotion

Check out these five things you can do to before asking for a promotion.

March 20, 2018
·
3 min read
·
Porschia Parker